Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial–Mesenchymal Transition, and Metastasis

1 May 2021

Abstract excerpt

One of the most frequently utilized cancer stem cell markers in human cancers, including colorectal cancer and breast cancer, is CD44. A glycoprotein, CD44, traverses the cell membrane and binds to many ligands, including hyaluronan, resulting in activation of signaling cascades. There are conflicting data, however, on expression of CD44 in relationship to subtypes of cancers. Moreover, the associations of CD44...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics
Share to Proteoglycans and glycosaminoglycans research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33961518
DOI: 10.1089/omi.2021.0025

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial–Mesenchymal Transition, and MetastasisPMID 33961518Read ↗

The Cancer Stem Cell Marker CD44 Play Key Roles in Immune Suppression/Evasion, Drug Resistance, Epithelial-Mesenchymal Transition, and Metastasis in Several Human CancersSemantic proximity Read ↗

Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic TargetSemantic proximity Read ↗

CD44 on cancer stem cell is a potential immunological and prognostic pan-cancer biomarkerSemantic proximity Read ↗

CD44 and its implication in neoplastic diseasesSemantic proximity Read ↗

CD44: a stemness driver, regulator, and marker—all in one?Semantic proximity Read ↗

Cancer Stem Cell Markers in Relation to Patient Survival Outcomes: Lessons for Integrative Diagnostics and Next-Generation Anticancer Drug DevelopmentSemantic proximity Read ↗

CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic nichesSemantic proximity Read ↗

Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosisSemantic proximity Read ↗

CD44: A Multifunctional Mediator of Cancer ProgressionSemantic proximity Read ↗

Cancer stem cells: The important role of CD markers, Signaling pathways, and MicroRNAsSemantic proximity Read ↗

Stemness-related markers in cancerSemantic proximity Read ↗

The prognostic value and immunological role of CD44 in pan-cancer studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.